Polish-Italian-Hungarian RAndomized ThrombEctomy Trial

Inclusion Criteria: * ST elevation acute myocardial infarction within 6 hours since pain onset, with 2 mm ST segment elevation in two lead * Minimum 3 mm ST segment elevation in one leads * Vessel reference diameter \> 2.5 mm * When vessel reference diameter ≥ 4,0 mm than additional distal protection device (filter) is needed during stent implantation Exclusion Criteria: * Contraindications to PCI (contrast allergy, no possibility to stent implantation) ASA, thienopirydins or GP IIb/IIIa inhibitors * Active bleeding or coagutopathy * Prior CABG or PCI * Known ejection fraction EF \<35% * Cardiogenic shock /SBP \< 90 mmHg, IABP and/or catheloamins usage/ * LBBB, pacemaker rhythm * Severe calcifications * Previous Myocardial infarction * Stroke history * Patient directly after reanimation * Known thrombocytopenia- platelets \< 100 000 * Pregnancy * Cancer disease * No future patient cooperation expected * Patient's taking part in the other clinical trials * Fibrynolisis directly administered before PCI * Renal insufficiency (creatynine \> 220 µmol/ml), hemodialysis * Contraindications to PCI (contrast allergy, no possibility to stent implantation) ASA, thienopirydins or GP IIb/IIIa inhibitors * Active bleeding or coagutopathy * Prior CABG or PCI * Known ejection fraction EF \<35% * Cardiogenic shock /SBP \< 90 mmHg, IABP and/or catheloamins usage/ * LBBB, pacemaker rhythm * Severe calcifications * Previous Myocardial infarction * Stroke history * Patient directly after reanimation * Known thrombocytopenia- platelets \< 100 000 * Pregnancy * Cancer disease * No future patient cooperation expected * Patient's taking part in the other clinical trials * Fibrynolisis directly administered before PCI * Renal insufficiency (creatynine \> 220 µmol/ml), hemodialysis * Liver insufficiency